Youna Oh

Title: Youna Oh: Innovator in CCR2 Antagonist Development

Introduction

Youna Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target chemokine receptor 2 (CCR2). His work is crucial for addressing various diseases, including rheumatoid arthritis and multiple sclerosis.

Latest Patents

Youna Oh holds a patent for "Piperazinyl 3-aminopyrrolidine derivatives as CCR2 antagonists." This invention relates to compounds that exhibit CCR2 antagonistic effects, which are beneficial for treating, preventing, or alleviating conditions such as rheumatoid arthritis, arteriosclerosis, multiple sclerosis, and asthma. The compounds described in the patent are characterized by a specific chemical formula and include various salts or isomers.

Career Highlights

Throughout his career, Youna Oh has worked with prominent companies in the pharmaceutical industry, including Yang Ji Chemical Co., Ltd. and Han Wha Pharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development.

Collaborations

Youna Oh has collaborated with several professionals in his field, including Jee Woong Lim and Jong-Hoon Kim. These collaborations have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Youna Oh is a distinguished inventor whose work on CCR2 antagonists has the potential to impact the treatment of various diseases significantly. His contributions to medicinal chemistry highlight the importance of innovation in addressing health challenges.